[1]刘大龙,辛 燕.脑血管药物洗脱支架与金属裸支架治疗椎动脉狭窄的效果比较[J].医学信息,2020,33(23):114-115,118.[doi:10.3969/j.issn.1006-1959.2020.23.033]
 LIU Da-long,XIN Yan.Comparison of Cerebrovascular Drug-eluting Stent and Metal Bare Metal Stent in the Treatment of Vertebral Artery Stenosis[J].Medical Information,2020,33(23):114-115,118.[doi:10.3969/j.issn.1006-1959.2020.23.033]
点击复制

脑血管药物洗脱支架与金属裸支架治疗椎动脉狭窄的效果比较()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年23期
页码:
114-115,118
栏目:
临床研究
出版日期:
2020-12-01

文章信息/Info

Title:
Comparison of Cerebrovascular Drug-eluting Stent and Metal Bare Metal Stent in the Treatment of Vertebral Artery Stenosis
文章编号:
1006-1959(2020)23-0114-03
作者:
刘大龙辛 燕
(兰州市第一人民医院神经内科1,质控科2,甘肃 兰州 730050)
Author(s):
LIU Da-longXIN Yan
(Department of Neurology1,Department of Quality Control2,Lanzhou First People’s Hospital,Lanzhou 730050,Gansu,China)
关键词:
脑血管病药物洗脱支架金属裸支架椎动脉狭窄
Keywords:
Cerebrovascular diseaseDrug-eluting stentBare metal stentVertebral artery stenosis
分类号:
R743.3
DOI:
10.3969/j.issn.1006-1959.2020.23.033
文献标志码:
A
摘要:
目的 观察研究脑血管药物洗脱支架与金属裸支架治疗椎动脉狭窄的临床疗效。方法 选取2018年2月~2019年2月在我院诊治的104例椎动脉狭窄患者为研究对象,采用随机数字表法分为对照组和观察组,各52例。对照组采用金属裸支架治疗,观察组采用脑血管药物洗脱支架治疗,比较术后6个月支架内再狭窄发生率、血流动力学指标改变(狭窄处峰值流速、狭窄处阻力指数、患侧寰椎段阻力指数)情况、Malek分级以及并发症发生情况。结果 术后6个月观察组支架内再狭窄发生率为7.67%,低于对照组的21.15%,差异有统计学意义(P<0.05);观察组狭窄处峰值流速、狭窄处阻力指数、患侧寰椎段阻力指数均低于对照组,差异有统计学意义(P<0.05);观察组Malek分级1级、2级分布率高于对照组,3级、4级低于对照组,差异有统计学意义(P<0.05);观察组并发症发生率为3.84%,低于对照组的11.53%,差异有统计学意义(P<0.05)。结论 脑血管药物洗脱支架治疗椎动脉狭窄与金属裸支架比较,支架内再狭窄发生率低,可显著改善患者狭窄处血流动力学,且并发症少,应用安全性高,值得临床应用。
Abstract:
Objective To observe and study the clinical efficacy of cerebrovascular drug-eluting stents and bare metal stents in the treatment of vertebral artery stenosis.Methods A total of 104 patients with vertebral artery stenosis who were diagnosed and treated in our hospital from February 2018 to February 2019 were selected as the research objects. They were divided into a control group and an observation group by a random number table method, with 52 cases in each group.The control group was treated with bare metal stent, observation group was treated with cerebrovascular drug-eluting stent. the incidence of restenosis in the stent, hemodynamic changes (peak velocity at stenosis, resistance index at stenosis, resistance index at atlantoaxial segment of affected side), Malek grade and complications were compared after 6 months.Results 6 months postoperatively, the incidence of restenosis in the stent in the observation group was 7.67%, which was lower than 21.15% in the control group,the difference was statistically significant (P<0.05); The resistance index of lateral atlas was lower than that of the control group,the difference was statistically significant (P<0.05); the distribution rate of Malek grade 1 and 2 in the observation group was higher than that of the control group, and grade 3 and 4 were lower than the control group,the difference was statistically significant (P<0.05); the incidence of complications in the observation group was 3.84%, which was lower than 11.53% in the control group,the difference was statistically significant (P<0.05).Conclusion Compared with metal bare metal stents, cerebrovascular drug-eluting stents have a lower incidence of in-stent restenosis, which can significantly improve the hemodynamics of patients with stenosis, with fewer complications, and high safety. It is worthy of clinical application.

参考文献/References:

[1]Jenkins JS,Stewart M.Endovascular treatment of vertebral artery stenosis[J].Prog Cardiovasc Dis,2017,59(6):619-625. [2]车武强,蒋雄京,董徽,等.支架术治疗颅外椎动脉近端粥样硬化性狭窄的效果[J].中华心血管病杂志,2017,45(1):34-38 [3]中华医学会神经病学分会,中华医学会神经病学分会神经血管介入协作组,急性缺血性脑卒中介入诊疗指南撰写组.中国急性缺血性脑卒中早期血管内介入诊疗指南[J].中华神经科杂志,2015,48(5):356-361. [4]李立,李天晓,薛绛宇,等.Apollo支架治疗椎动脉起始部和颅内段狭窄的疗效比较[J].中国脑血管病杂志,2012,9(11):585-589. [5]Jiang Y,Xu X,Wen Z,et al.In-stent restenosis after vertebral artery stenting[J].Int J Cardiol, 2015(187):430-433. [6]李朱勤,刘武,邓宇平,等.自膨式与球囊扩张支架治疗椎动脉颅内段狭窄患者的临床疗效对比分析[J].现代诊断与治疗,2016,27(2):200-202. [7]郭彦勇,吕献军,张正祥,等.颅内支架置入围手术期并发症的危险因素分析[J].中风与神经疾病杂志,2015,32(2):173-174. [8]朱凤水,李慎茂,焦力群,等.椎动脉起始部合并相邻锁骨下动脉重度狭窄支架置入的治疗[J].中国脑血管病杂志,2015,6(1):33-36. [9]钟涛,刘东涛,马向科,等.无症状性颈动脉狭窄患者不同治疗方式后的临床结局[J].中国卒中杂志,2018,13(8):790-794. [10]赵同源,李钊硕,薛降宇,等.药物洗脱支架与金属裸支架治疗椎动脉开口狭窄的对照研究[J].中华神经医学杂志,2015,14(4):506-510.

相似文献/References:

[1]祖 赛,窦志杰,卢丹丹,等.非急性脑卒中患者脑白质疏松程度与 血尿酸水平的相关性研究[J].医学信息,2018,31(05):101.[doi:10.3969/j.issn.1006-1959.2018.05.033]
 ZU Sai,DOU Zhi-jie,LU Dan-dan,et al.Study on the Correlation between the Degree of Leukoaraiosis and the Level of Blood Uric Acid in Patients with non Acute Stroke[J].Medical Information,2018,31(23):101.[doi:10.3969/j.issn.1006-1959.2018.05.033]
[2]王福星.醒脑静注射液治疗急性重症脑血管病的临床疗效[J].医学信息,2020,33(18):162.[doi:10.3969/j.issn.1006-1959.2020.18.054]
 WANG Fu-xing.Clinical Observation of Xingnaojing Injection in the Treatment of Acute Severe Cerebrovascular Disease[J].Medical Information,2020,33(23):162.[doi:10.3969/j.issn.1006-1959.2020.18.054]

更新日期/Last Update: 1900-01-01